Palisade Capital Management’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-16,000
| Closed | -$102K | – | 416 |
|
|
2020
Q1 | $102K | Buy |
16,000
+2,000
| +14% | +$12.8K | ﹤0.01% | 411 |
|
|
2019
Q4 | $146K | Sell |
14,000
-4,100
| -23% | -$42.8K | ﹤0.01% | 405 |
|
|
2019
Q3 | $71K | Buy |
+18,100
| New | +$71K | ﹤0.01% | 420 |
|
|
2015
Q4 | – | Sell |
-70,937
| Closed | -$6.52M | – | 544 |
|
|
2015
Q3 | $6.52M | Buy |
70,937
+65,437
| +1,190% | +$6.02M | 0.19% | 189 |
|
|
2015
Q2 | $483K | Buy |
+5,500
| New | +$483K | 0.01% | 475 |
|